Experts Agree On Domino Effect Of German Cannabis Legalization, Alert Companies About Rigorous Quality Control Standards & Other Challenges
Germany’s recent partial legalization of cannabis has shaken up the industry and moved marijuana stocks. Will it have a domino effect on other European countries? How easy it is for the cannabis companies to jump on this opportunity and establish their presence in the German cannabis market?
To find out, we continue our conversation with industry experts such as Dr. Constantin von der Groeben, a managing director of Demecan – the only German vertically integrated medicinal cannabis company; Denise Faltischek, a chief strategy officer and Head of International of a Canadian cannabis giant Tilray Brands (NASDAQ:TLRY) (TSX:TLRY), Jürgen Bickel, co-founder and managing director of Canopy Growth’s (NASDAQ:CGC) Germany-based vaporization company Storz & Bickel; and Adam Wilks, CEO of Carma HoldCo. – the global licensing company.
In the first part of our conversation HERE, these industry experts shared their opinions on what the reform means, its impact and how the market will develop. Now, Wilks explains what this means for his global licensing company behind the nation’s fastest-growing celebrity cannabis and lifestyle brands, working with icons like Mike Tyson, Ric Flair, Future and Hulk Hogan.
“Germany’s cannabis reform represents an exciting opportunity for our company and the celebrity brands we work with, and presents a new market primed for growth and expansion,” Wilks told Benzinga. “For our company, this reform means an opportunity to further solidify our presence in Europe after TYSON 2.0’s opening of a new branded coffee shop in Amsterdam last year, and capitalize on the emerging cannabis industry in …